State Street Corp. Updates Passive Stake in AngioDynamics Inc.
Ticker: ANGO · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1275187
| Field | Detail |
|---|---|
| Company | Angiodynamics Inc (ANGO) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street Corp. still holds AngioDynamics stock, no big changes here.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of AngioDynamics Inc. common stock as of December 31, 2023. This filing updates their previous disclosure, showing their continued passive investment in the medical device company. For investors, this means a significant institutional holder maintains its position, which can signal stability but doesn't suggest any active changes in AngioDynamics' operations or strategy.
Why It Matters
This filing confirms State Street Corporation's ongoing passive investment in AngioDynamics, providing transparency on institutional ownership without indicating any intent to influence company management.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not signal any immediate risks or opportunities for AngioDynamics Inc.
Analyst Insight
A smart investor would note that State Street Corporation continues to hold a passive stake in AngioDynamics Inc., suggesting no immediate red flags or catalysts from this institutional investor. This filing is a routine update and doesn't warrant any immediate trading action based solely on this information.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- AngioDynamics Inc. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring this filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
- 03475V101 (other) — the CUSIP number for AngioDynamics Inc. common stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' section and the title 'SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING'.
Who is the reporting person in this filing?
The reporting person is STATE STREET CORPORATION, as clearly identified under '1. NAME OF REPORTING PERSON: STATE STREET CORPORATION'.
What is the subject company whose securities are being reported?
The subject company is ANGIODYNAMICS INC, as indicated by 'NAME OF ISSUER: ANGIODYNAMICS INC' and 'COMPANY CONFORMED NAME: ANGIODYNAMICS INC'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as stated under 'DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT: 12/31/2023'.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the common stock of AngioDynamics Inc. is 03475V101, as listed under 'CUSIP NUMBER: 03475V101'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding ANGIODYNAMICS INC (ANGO).